Masahiko Kato Selected Research

Eosinophil Cationic Protein

12/2016	IP-10 Is Elevated in Virus-Induced Acute Exacerbations in Childhood Asthma.
9/2015	Virus detection and cytokine profile in relation to age among acute exacerbations of childhood asthma.
2/2011	Different cytokine profile and eosinophil activation are involved in rhinovirus- and RS virus-induced acute exacerbation of childhood wheezing.
1/2011	Differential effects of corticosteroids on serum eosinophil cationic protein and cytokine production in rhinovirus- and respiratory syncytial virus-induced acute exacerbation of childhood asthma.
1/2010	Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiko Kato Research Topics

Disease

25	Heart Failure 06/2022 - 03/2002
19	Asthma (Bronchial Asthma) 01/2022 - 04/2002
16	Insulin Resistance 06/2022 - 03/2007
13	Type 2 Diabetes Mellitus (MODY) 06/2022 - 01/2013
10	Inflammation (Inflammations) 04/2017 - 01/2002
5	Fibrosis (Cirrhosis) 01/2022 - 07/2005
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2005
5	Liver Cirrhosis (Hepatic Cirrhosis) 07/2006 - 01/2004
4	Hypertension (High Blood Pressure) 01/2020 - 09/2007
4	Infections 05/2016 - 09/2008
3	Bacterial Infections (Bacterial Infection) 01/2022 - 02/2004
3	Respiratory Sounds (Crackle) 01/2022 - 02/2011
3	Hyperuricemia 01/2022 - 12/2005
3	Pneumonia (Pneumonitis) 11/2021 - 05/2011
3	Obesity 01/2021 - 07/2006
3	Malnutrition (Nutritional Deficiencies) 01/2021 - 01/2004
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 04/2017 - 05/2003
3	Respiratory Syncytial Virus Infections 10/2013 - 05/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2022 - 01/2004
2	Edema (Dropsy) 04/2019 - 12/2012
2	Death (Near-Death Experience) 12/2018 - 03/2002
2	Virus Diseases (Viral Diseases) 12/2016 - 02/2004
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2016 - 03/2003
2	Leukemia 10/2016 - 03/2003
2	Neoplasms (Cancer) 07/2013 - 08/2008
2	Left Ventricular Dysfunction 11/2010 - 05/2004
2	Coronary Stenosis (Coronary Artery Stenosis) 11/2010 - 05/2003
2	Asphyxia (Suffocation) 01/2008 - 01/2006
2	Diabetes Mellitus 09/2007 - 07/2006
2	Airway Remodeling 12/2002 - 10/2002
1	Arthritis (Polyarthritis) 04/2022
1	rhupus syndrome 04/2022
1	Hypernatremia 03/2022
1	Weight Loss (Weight Reduction) 01/2022
1	COVID-19 11/2021
1	Spinal Cord Diseases 09/2021
1	Sleep Wake Disorders 07/2021
1	Hyperventilation 07/2021
1	Overactive Urinary Bladder (Overactive Bladder) 01/2021
1	Premature Birth (Birth, Premature) 01/2021
1	Rupture 01/2021
1	Chorioamnionitis 01/2021

Drug/Important Bio-Agent (IBA)

22	CytokinesIBA 04/2020 - 01/2003
12	ChemokinesIBA 04/2020 - 01/2006
11	Insulin (Novolin)FDA Link 01/2022 - 01/2010
7	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2012
6	Interleukin-5 (Interleukin 5)IBA 04/2020 - 01/2010
5	C-Reactive ProteinIBA 01/2022 - 02/2004
5	Uric Acid (Urate)IBA 01/2022 - 12/2005
5	Eosinophil Cationic ProteinIBA 12/2016 - 01/2010
5	AntigensIBA 09/2015 - 10/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 01/2003
4	AdiponectinIBA 01/2020 - 09/2007
4	Losartan (Cozaar)FDA LinkGeneric 04/2017 - 02/2004
4	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 08/2008
4	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2014 - 01/2010
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2011 - 04/2008
4	Interleukin-6 (Interleukin 6)IBA 02/2011 - 01/2003
4	Serum AlbuminIBA 07/2006 - 01/2004
4	Branched-Chain Amino AcidsIBA 07/2006 - 01/2004
3	AllergensIBA 01/2022 - 11/2009
3	Immunoglobulin E (IgE)IBA 01/2022 - 05/2014
3	Proteins (Proteins, Gene)FDA Link 05/2011 - 01/2004
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2011 - 04/2008
2	IncretinsIBA 01/2022 - 01/2020
2	AntibodiesIBA 09/2021 - 05/2014
2	Pharmaceutical PreparationsIBA 01/2021 - 04/2017
2	Interleukin-8 (Interleukin 8)IBA 04/2020 - 04/2008
2	Fatty Acid-Binding ProteinsIBA 01/2019 - 01/2017
2	C-PeptideIBA 03/2018 - 01/2013
2	DiureticsIBA 01/2017 - 02/2014
2	OvalbuminIBA 01/2013 - 10/2002
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2010 - 12/2002
2	Adenosine (Adenocard)FDA LinkGeneric 11/2010 - 12/2006
2	Peptides (Polypeptides)IBA 11/2008 - 08/2003
2	Neurotransmitter Agents (Neurotransmitter)IBA 09/2003 - 01/2003
2	Phenobarbital (Luminal)FDA Link 05/2003 - 05/2003
1	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2022
1	Anti-Citrullinated Protein AntibodiesIBA 04/2022
1	cyclic citrullinated peptideIBA 04/2022
1	Tolvaptan FDA Link 03/2022
1	MacrolidesIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Penicillins (Penicillin)FDA Link 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2022
1	ipragliflozinIBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Irritants (Vesicants)IBA 07/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 12/2020

Therapy/Procedure

7	Therapeutics 10/2016 - 09/2005
3	Cardiopulmonary Resuscitation (CPR) 12/2018 - 01/2013
2	Catheter Ablation 03/2019 - 01/2018
2	Oral Administration 10/2013 - 07/2005
1	Nursing Care 06/2022